Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: A comparative study with rat chondrocytes and cartilage entities

British Journal of Pharmacology

Volumn 124, Issue 8, 1998, Pages 1719-1727

  Cipolletta, Christine ^a   Jouzeau, Jean Yves ^a   Gegout Pottie, Pascale ^a   Presle, Nathalie ^a   Bordji, Karim ^a   Netter, Patrick ^a   Terlain, Bernard ^a  

^a CNRS   (France)

Author keywords

Aminoguanidine; Cartilage organ system; Chondrocytes; Interleukin 1; N( ) monomethyl L arginine; N( ) nitro L arginine methyl ester; Nitric oxide; Proteoglycan synthesis; S aminoethylisothiourea; S methylisothiourea

Indexed keywords

AMINOETHYLISOTHIOURONIUM; AMINOGUANIDINE; ARGININE METHYL ESTER; DEXAMETHASONE; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARTILAGE; CARTILAGE DISEASES; CHONDROCYTES; DEXAMETHASONE; ENZYME INHIBITORS; INTERLEUKIN-1; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROTEOGLYCANS; RATS; RATS, WISTAR;

EID: 0031817293     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702005     Document Type: Article

References (49)

1. AREND, W.P. & DAYER, J.M. (1990). Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis. Rheum., 33, 305-315.
2. BECKMAN, J.S. & KOPPENOL, W.E. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol., 271, C1424-C1437.
3. BLANCO, F.J., GENG, Y. & LOTZ, M. (1995). Differentiation-dependent effects of IL-1 and TGF-β on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J. Immunol., 154, 4018-4026.
4. CANNON, G.W., OPENSHAW, S.J., HIBBS, J.B., HOIDAL, J.R., HELICKSTEADT, T.P. & GRIFFITHS, M.M. (1996). Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis. Rheum., 39, 1677-1684.
5. CLANCY, R.M., REDISKE, J., TANG, X., NIJHER, N., FRENKEL, S., PHILIPS, M. & ABRAMSON, S.B. (1997). Outside-in signaling in chondrocytes. J. Clin. Invest., 100, 1789-1796.
6. COLLIN-OSDOBY, P., NICKOLS, G.A. & OSDOBY, P. (1995). Bone cell function, regulation, and communication: a role for nitric oxide. J. Cell. Biochem., 57, 399-408.
7. DINGLE, J.T. (1991). Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglundins in articular cartilage damage and repair. J. Rheumatol., 18, 30-37.
8. EVANS, C.H., WATKINS, S.C. & STEFANOVIC-RACIC, M. (1996). Nitric oxide and cartilage metabolism. Meth. Enzymol., 269, 75-88.
9. FARRELL, A.J., BLAKE, D.R., PALMER, R.M.J. & MONCADA, S. (1992). Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis., 51, 1219-1222.
10. FARRELL, A.J. & BLAKE, D.R. (1996). Nitric oxide. Ann. Rheum. Dis., 55, 7-20.
11. FÖRSTERMANN, U. & KLEINERT, H. (1995). Nitric oxide synthase: expression and expressional control of the three isoforms. Arch. Pharmacol., 352, 351-364.
12. FUKUDA, K., KUMANO, F., TAKAYAMA, M., SAITO, M., OTANI, K. & TANAKA, S. (1995a). Zonal differences in nitric oxide synthesis by bovine chondrocytes exposed to interleukin-1. Inflamm. Res., 44, 434-437.
13. FUKUDA, K., OHTANI, K., DAN, H. & TANAKA, S. (1995b). Interleukin-1 inhibits keratan sulfate production by rabbit chondrocytes: possible role of prostaglandin E2. Inflamm. Res., 44, 178-181.
14. GRABOWSKI, P.S., MACPHERSON, H. & RALSTON, S.H. (1996). Nitric oxide production in cells derived from the human joint. Br. J. Rheumatol., 35, 207-212.
15. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138.
16. HAÜSELMANN, H.J. AYDELOTTE, MB., SCHUMACHER, B.L., KUETTNER, K.E., GITELIS, S.H. & THONAR, E.J.M.A. (1992). Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix, 12, 116-129.
17. HAÜSELMANN, H.J., OPPLIGER, L., MICHEL, B.A. STEFANOVIC-RACIC, M. & EVANS, C.H. (1994). Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett., 352, 361-364.
18. HAÜSELMANN, H.J., STEFANOVIC-RACIC, M., MICHEL, B.A. & EVANS, C.H. (1998). Differences in nitric oxide production by superficial and deep human articular chondrocytes: implication for proteoglycan turnover in inflammatory joint diseases. J. Immunol., 160, 1444-1448.
19. IALENTI, A., IANARO, A., MONCADA, S. & DI ROSA, M. (1992). Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol., 211, 177-182.
20. JANG, D., SZABO, C. & MURRELL, G.A.C. (1996). S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage. Eur. J. Pharmacol., 312, 341-347.
21. JARVINEN, T.A.H., MOILANEN, T., JÄRVINEN, T.L.N. & MOILAEN, E. (1995). Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Medial. Inflamm., 4, 107-111.
22. KNOWLES, R.G. & MONCADA, S. (1994). Nitric oxide synthases in mammals. Biochem. J., 298, 249-258.
23. KUETTNER, K.E., PAULI, B.U., GALL, G., MEMOLI, V.A. & SCHENK, R.K. (1982). Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics and morphology. J. Cell. Biol., 93, 743-750.
24. LASKIN, J.D., HECK, D.E. & LASKIN, D.L. (1994). Multifunctional role of nitric oxide in inflammation. Trends. Endocrinol. Metab., 5, 377-382.
25. LUO, L., CRUZ, T. & MCCULLOCH, C. (1997). Interleukin-1-induced calcium signalling in chondrocytes requires focal adhesions. Biochem. J., 324, 653-658.
26. LYONS-GIORDANO, B., PRATTA, M.A., GALBRATH, W., DAVIS, G.L. & ARNER, E.C. (1993). Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2. Exp. Cell. Res., 206, 58-62.
27. MCCARTNEY-FRANCIS, N., ALLEN, B.J., MIZEL, D.E., ALBINA, J.E., XIE, Q.W., NATHAN, C.F. & WAHL, S.M. (1993). Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med., 178, 749-754.
28. MURRELL, G.A.C., JANG, D. & WILLIAMS, R.J. (1995). Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun., 206, 15-21.
29. MURRELL, G.A.C., DOLAN, M.M., JANG, D. SZABO, C., WARREN, M.M. & HANNAFIN, J.A. (1996). Nitric oxide: an important articular free radical. J. Bone. Joint. Surg., 78-A, 265-274.
30. O'BYRNE, E.M., PARKER, D.T., ROBERTS, E.D., GOLDBERG, R.L., MACPHERSON, L.L., BLANCUZZI, V., WILSON, D., SINGH, H.N., LUDEWIG, R. & GANU, V.S. (1995). Oral administration of a matrix metalloproteinase inhibitor, CGS27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbit. Inflamm. Res., Suppl 2, S117-S118.
31. PALMER, R.M.J., ANDREWS, T.Y., FOXWELL, N.A. & MONCADA, S. (1992). Glucocorticoids do not affect the induction of novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem. Biophys. Res. Commun., 188, 209-215.
32. PALMER, R.M.J., HICKERY, M.S., CHARLES, I.G., MONCADA, S. & BAYLISS, M.T. (1993). Induction of nitric oxide synthase in human chondrocytes. Biochem. Biophys. Res. Commun., 193, 398-405.
33. PETERSON, D.A., PETERSON, D.C., ARCHER, S. & WEIR, E.K. (1992). The non specificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun., 187, 797-801.
34. RATHAKAISHNAN, C., TIKU, K., RAGHAVAN, A. & TIKU, M.L. (1992). Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemiluminescence and hydrogen peroxide secretion. J. Bone. Min. Res., 7, 1139-1143.
35. REDISKE, J.J., KOEHNE, C.F., ZHANG, B. & LOTZ, M. (1994). The inducible production of nitric oxide by articular cell types. Osteoarthritis. Can., 2, 199-206.
36. REES, D.D., PALMER, R.M.J., SCHULZ, R., HUDSON, H.F. & MONCADA, S. (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
37. STADLER, J., STEFANOVIC-RACIC, M., BILLAR, T.R., CURRAN, R.D. MCINTYRE, L.A., GEORGESCU, H.I., SIMMONS, R.L. & EVANS, C.H. (1991). Articular chondrocytes syhthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol., 197, 3915-3920.
38. STEFANOVIC-RACIC, M., MEYERS, K., MESCHTER, C., COFFEY, J.W., HOFFMAN, R.A. & EVANS, C.H. (1994). N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis. Rheum., 37, 1062-1069.
39. STEFANOVIC-RACIC, M., MEYERS, K., MESCHTER, C., COFFEY, J.W., HOFFMAN, R.A. & EVANS, C.H. (1995). Comparison of nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J. Rheumutol., 22, 1922-1928.
40. STEFANOVIC-RACIC, M., MORALES, T.M., TASKIRAN, D., McINTYRE, L.A. & EVANS, C.H. (1996). The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ culture. J. Immunol., 15, 1213-1220.
41. STICHTENOTH, D.O., GUTZKI, F.M., TSIKAS, D., SELVE, N., BODEBOGER, S.M., BÖGER, R.H. & FRÖLICH, J.C. (1994). Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann. Rheum. Dis., 53, 547-549.
42. SOUTHAN, G.J., SZABO, C. & THIEMERMANN, C. (1995). Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol., 114, 510-516.
43. TASKIRAN, D., STEFANOVIC-RACIC, M., GEORGESCU, H. & EVANS, C. (1994). Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biohem. Biophys. Res. Commun., 200, 142-148.
44. TSAI, A.-L. (1994). How does NO activate hemeproteins? FEBS Lett., 341, 141-145.
45. UEKI, Y., MIYAKE, S., TOMINAGA, Y. & EGUCHI, K. (1996). Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23, 230-236.
46. VAN BEUNINGEN, H.M., VAN DER KRAAN, P., ARNTZ, O.J. & VAN DEN BERG, W. (1993). Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor β: studies in an anatomically intact cartilage in vitro and in vivo. Ann. Rheum. Dis., 52, 185-191.
47. VAN DE LOO, F.A.J., JOOSTEN, L.A.B., VAN LENT P.L.E.M., ARNTZ, O.J. & VAN DEN BERG, W. (1995). Role of interleukin-1, tumor necrosis factor α and interleukin-6 in cartilage proteoglycan metabolism and destruction. Arthritis Rheum., 38, 164-172.
48. WILLIS D, MOORE A.R., FREDERICK, R. & WILLOUGHBY, D.A. (1996). Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Med., 2, 87-89.
49. WESTACOTT, C.I., WEBB, G.R. WARNOCK, M.G., SIMS, J.V. & ELSON, C.J. (1997). Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis. Rheum., 40, 1282-1291.